Tuberculosis of respiratory tract and chemotherapy: the influence on the state of vaginal microbiota


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim. To assess the state of the vaginal microbiota in patients with tuberculosis (TB) of the respiratory tract during the monitoring of chemotherapy (CTH). Materials and methods. The study “case-control” was conducted in compliance with STROBErecommendations, where the «case» meant the presence of TB of the respiratory tract and CTH; “control” - the absence of TB of the respiratory tract and CTH. 108 women of reproductive age were examined. They were stratified into 2 groups: group 1 - 54 patients with TB of the respiratory tract treated with CTH; group 2 - 54 women without TB of the respiratory tract and CTH. The standard obstetrical-gynecological and phthisiological researches were used; special study of vaginal microbiota was conducted with the use of “Femoflor” test system with a realtime polymerase chain reaction and quantitative characteristics of 28 conditionally pathogenic microorganisms. Statistical data analysis was performed using scripts in the R programming language version 3.5 in the R Studio environment. Results. With prolongation of therapy (for 60 and 150 days after CTH), a statistically significant decrease in Lactobacillus spp. - 6 [5,7; 6,6], 0 [0; 4] и 0 [0; 3] (р40,0001), a gradual increase in the majority of associates of conditionally pathogenic microflora (the most indicative were Gardnerella vaginalis and Candida spp.) were noted in microbiota. The m icroscopic characteristic of the vaginal biotope was the presence of normocenosis prior to CXT in the vast majority in group 1 - 47 (87%). 60 and 150 days after CXT, there was absence of normocenosis - 0 (0%), and statistically significant increase in the incidence of dysbiosis and an inflammatory bowel disease was 29 (54%) (р<0,0001) and 12 (22%) (р=0,02); 25 (46%) (р<0,0001) and 29 (54%). Conclusion. The presence of 2 aggressive factors - TB of the respiratory tract and CXT damage the vaginal biotope resulting in formation of aerobic-anaerobic dysbiosis. No statistically significant relationship was observed between the development of vaginal dysbiosis and the clinical form of TB of the respiratory tract, the severity of the specific process and the selected chemotherapy regimen. Further studies in this direction should be continued.

Full Text

Restricted Access

About the authors

Svetlana I. Kayukova

Central Research Institute of Tuberculosis

Email: kajukovalnp@gmail.com
PhD in Medical Sciences, Senior Researcher

Atadjan E. Ergeshov

Central Research Institute of Tuberculosis

Email: v.kirilina@ctri.ru
M.D., Professor, Director

Zhanna S. Lulueva

Central Research Institute of Tuberculosis

Email: zhanna_Lulueva@mail.ru
graduate student

Tatevik R. Bagdasaryan

Central Research Institute of Tuberculosis

Email: tatev0812@mail.ru
PhD in Medical Sciences, Head of the 1st Therapeutic department

Andrey E. Donnikov

National Medical Research Center for Obstetrics, Gynecology and Perinatology named After Academician V.I. Kulakov of the Ministry of Health of Russia

Email: a_donnikov@oparina4.ru
PhD in Medical Sciences, Head of the Laboratory of Molecular Genetic Methods

Svetlana P. Shelykalina

National Research Medical University named after N.I. Pirogov of the Ministry of Health of Russia

Email: svetlanath@gmail.com
PhD in Medical Sciences, Associate Professor of the Department of Medical Cybernetics and Informatics

Natalya L. Karpina

Central Research Institute of Tuberculosis

Email: natalya-karpina@rambler.ru
M.D., Professor, Head of the Center for Diagnosis and Rehabilitation of Respiratory Diseases

Natalya I. Evseeva

Central Research Institute of Tuberculosis

Email: leopardic@inbox.ru
junior researcher, Clinical and Diagnostic Department

Elena V. Uvarova

National Medical Research Center for Obstetrics, Gynecology and Perinatology named After Academician V.I. Kulakov of the Ministry of Health of Russia

Email: elena-uvarova@yandex.ru
M.D., Professor, Corresponding Member of the RAS, Head of the Department of Pediatric and Adolescent Gynecology (2nd Gynecological Department)

References

  1. Ворошилина Е.С., Зорников Д.Л., Плотко Е.Э. Нормальное состояние микробиоценоза влагалища: оценка с субъективной, экспертной и лабораторной точек зрения. Вестник Российского государственного медицинского университета. 2017; 2: 42-6. [Voroshilina E.S., Zornikov D.L., Plotko E.E. Normal condition of vaginal microbiocenosis: assessment from a subjective, expert and laboratory point of view. Bulletin of the Russian State Medical University. 2017; 2: 42-6. (in Russian)].
  2. Efared B., Sidibe I.S., Erregad F., Hammas N., Chbani L., Fatemi H. E. Female genital tuberculosis: a clinicopathological report of 13 cases. J. Surg. Case Rep. 2019; 2019(3): rjz083.10.1093/jscr/rjz083.
  3. Sharma B.J., Sneha J., Singh U.B., Kumar S., Kumar R. K, Singh N. et al. Effect of antitubercular therapy on endometrial function in infertile women with female genital tuberculosis. Infect. Disord. Drug Targets. 2016; 16(2): 101-8.
  4. Yang T.W., Park H.O., Jang H.N., Yang J.H., Kim S.H., Moon S.H., et al. Side effects associated with the treatment of multidrug-resistant tuberculosis at a tuberculosis referral hospital in South Korea. Medicine(Baltimore). 2017; 96(28): e7482. 10.1097/MD.0000000000007482.
  5. Ворошилина Е.С., Плотко Е.Э., Исламиди Д.К., Лаврентьева И.В., Зорников Д.Л. Микробиоценоз влагалища с точки зрения ПЦР в реальном времени. Возможности коррекции дисбиотических нарушений влагалища. Учебное пособие. Екатеринбург; 2018. 71 с. [Voroshilina E.S., Plotko E.E. Islamidi D.K., Lavrentiev I.V., Zornikov D.L. Vaginal microbiocnosis from the point of view of real-time PCR. Possibilities for correcting dysbiotic disorders of the vagina. Tutorial. Yekaterinburg. 2018. 71 p. (in Russian)].
  6. Cartwright C.P., Pherson A.J., Harris A.B., Clancey M.S., Nye M.B. Multicenter study establishing the clinical validity of a nucleic-acid amplification-based assay for the diagnosis of bacterial vaginosis. Diagn. Microbiol. Infect. Dis. 2018; 92(3): 173-8. 10.1016/j.diagmicrobio.2018.05.022.
  7. Клинические рекомендации по диагностике и лечению заболеваний, сопровождающихся патологическими выделениями из половых путей женщин. М.: Российское общество акушеров-гинекологов; 2019. 57 с. [Clinical recommendations on diagnosis and treatment of diseases accompanied by pathological vaginal discharge in women. Russian Society of Obstetricians and Gynecologists. Moscow. 2019. 57p. (in Russian)].
  8. Вольф С.Б. Нежелательные побочные реакции на химиотерапию туберкулеза. Журнал Гродненского государственного медицинского университета. 2016; 3: 141-6. [Wolf S.B. Undesirable adverse reactions to chemotherapy of tuberculosis. Journal of Grodno State Medical University. 2016; 3: 141-6. (in Russian)].

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2020 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies